Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
Wednesday, March 10, 2010 - 08:21
in Health & Medicine
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).